SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-11-018941
Filing Date
2011-04-06
Accepted
2011-04-06 17:11:36
Documents
1
Period of Report
2011-04-06

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 16015
  Complete submission text file 0001104659-11-018941.txt   17528
Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address SUITE 300, 5 PLACE VILLE MARIE MONTREAL A8 H3B 5E7
Business Address SUITE 300, 5 PLACE VILLE MARIE MONTREAL A8 H3B 5E7 514-283-0869
BDC CAPITAL INC. (Reporting) CIK: 0001430885 (see all company filings)

State of Incorp.: A8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 11743847